06/02/2026
jeffreydachmd.com/2026/06/magnesium-for-prevention-and-treating-of-coronary-artery-disease/ Magnesium For Prevention and Treatment of Coronary Artery Disease. A shocking number of Americans suffer from coronary artery disease. Millions are now taking statin drugs, blood pressure pills, water pills and other medications, yet the epidemic continues. What if the answer lies in a simple, inexpensive mineral that most doctors overlook? Magnesium.
In my office, I see patients every day with coronary artery disease, high blood pressure, and cardiac arrythmias. Many have low magnesium levels on testing the RBC Magnesium. When we correct the magnesium deficiency with diet and supplementation, the results are often dramatic: better energy, fewer symptoms, and improved lab markers. Why does magnesium work so well? It is not one single effect. It works through multiple mechanisms that directly address the root causes of atherosclerosis and coronary artery disease.
Important Point: Magnesium is not a drug. It is a natural mineral cofactor for hundreds of enzymes in the body.
Here are the key reasons magnesium is so effective:
1. Anti-Inflammatory Properties
In 2006, Dr. Stephan J Ott demonstrated that coronary artery plaque is fundamentally a polymicrobial biofilm demonstrated by multiple independent labs using 16s ribosome genetic sequencing of atherosclerotic plaque specimens. The plaque in your arteries is not just a passive buildup of cholesterol. It is an active infectious process driven by the microbes originating in the gut and pharynx causing immune reaction and calcification. Infection is one of the strongest triggers in the human body for an inflammatory reaction, thus causing soft tissue calcification in response to intense inflammation. (1)
Inflammatory Pathways Activated
Low magnesium activates inflammatory pathways such as NF-κB and the NLRP3 inflammasome, raising cytokines like CRP, IL-6, and TNF-α. This promotes plaque formation, endothelial activation, and monocyte recruitment. Magnesium supplementation reliably lowers these inflammatory markers. Multiple randomized controlled trials and meta-analyses confirm this benefit, especially in patients who are deficient.
In 2022, Dr. Nicola Veronese did a meta-analysis of 17 randomized trials and found significant reductions in CRP (C-reactive protein, a non-specific inflammatory marker, and other inflammatory markers with magnesium supplementation. The magnesium calms down the inflammatory and immune-driven progression of atherosclerotic plaque. (2)
2. Metabolism and Mitochondrial Function
Magnesium is the single most important nutrient for our mitochondria, the power plants inside every cell. Magnesium is required for ATP synthesis, the Tricarboxylic Acid (TCA) cycle, and electron transport chain enzymes. Without adequate magnesium, mitochondria cannot produce energy efficiently. This leads to increased oxidative stress, calcium overload, and impaired energy metabolism in heart muscle and vascular cells.
Magnesium deficient mitochondria means more inflammation, and inhibition of the reverse cholesterol transport mechanism. Restoring magnesium improves ATP production and cardiac diastolic function, which is especially helpful in heart failure with preserved ejection fraction.
In 2020, Drs. Man Liu and Samuel Dudley reviewed the many mechanisms of magnesiums benefits and stated that magnesium(Mg) supplementation improves mitochondrial function and cardiac diastolic performance in diabetics, The authors write:
In this review, we discuss the possible mechanisms by which Mg deficiency plays detrimental roles in cardiovascular diseases and review the results of clinical trials of Mg supplementation for heart failure, arrhythmias and other cardiovascular diseases…Mg supplementation has shown significant therapeutic effects in HF [heart failure] and CVD [cardio-vascular disease] …. It has also been shown to improve arrhythmias including torsades de pointes (TdP, polymorphic ventricular tachycardia with marked QT prolongation on the electrocardiogram), atrial fibrillation (AF) , ventricular arrhythmias (VA), and arrhythmias in acute myocardial infarction (MI).
3. Antioxidant Properties
Arterial wall breaks are induced by sheer stress at arterial bifurcations, allowing entrance of poly-microbial infection and oxidized LDL particles which incite inflammation, soft tissue calcification and progression of atherosclerotic plaque. Microbial infection of the arterosclerotic plaque, inflammation and calcification and oxidative stress are the initiating events of atherosclerosis.
Magnesium deficiency increases reactive oxygen species (ROS) from mitochondria and depletes antioxidant defenses such as superoxide dismutase and glutathione. At the cellular level, magnesium stabilizes cell membranes, supports enzymatic antioxidants, and reduces lipid peroxidation. It directly counters oxidative damage to cells.The comprehensive review by Drs. Man Liu and Samuel Dudley details these antioxidant mechanisms and their importance in cardiovascular protection.
4. Nitric Oxide Synthesis and Endothelial Function
The endothelium is the inner lining of your arteries, and this is the weak link in vascular health. Endothelial dysfunction means the arteries become stiff, constricted, and subject to damage. Enter Nitric Oxide, the protector of endothelial function. Magnesium is essential for endothelial nitric oxide synthase (eNOS) activity and nitric oxide (NO) production, which keeps vessels dilated and healthy.
Magnesium deficiency with low magnesium RBC levels will reduce nitric oxide production (NO), increase adhesion molecules, and promote vasoconstriction and thrombosis. Magnesium supplementation improves flow-mediated dilation, the standard clinical test of endothelial function, and exercise tolerance in patients with coronary artery disease.
Shecter Oral Magnesium Improves Endothelial Function
A landmark randomized trial in 2000 by Dr. Michael Shechter in Circulation showed that oral magnesium therapy significantly improved endothelial function in patients with coronary artery disease. This is one of the most cited studies in the field. (4)
5. Reduction in Atherosclerotic Plaque
Clinical Evidence from a 2019 Randomized Trial
Further strong support comes from a well-designed 2019 randomized, double-blind, placebo-controlled trial by Dr. Hamid Reza Talari. In this study, diabetic patients on hemodialysis received a modest dose of only 150 mg of magnesium oxide, one of the cheapest and poorly absorbed forms of magnesium. The effect of magnesium supplementation was studied with ultrasound imaging of the carotid arteries. Despite the conservative dose and lower absorption rate, the results were impressive and wide-ranging:
Vascular Health:
In the 2019 study by Dr. Hamid Reza Talari’s using ultrasound imaging to measure carotid intima thickness, there was significant reduction in mean carotid intima-media thickness (CIMT), meaning less atherosclerotic plaque buildup in the carotid arteries. The carotid arteries are the two large arteries (right and left) in the neck which supply blood flow to the brain.
Glycemic Control and Insulin Sensitivity:
Dr. Talari’s study also showed magnesium decreases fasting insulin, lowers HbA1c, lowers high-sensitivity CRP (hs-CRP), increases total antioxidant capacity (TAC) and lowers cholesterol.
Dr. Talari’s is particularly convincing because it was conducted in a very high-risk population, in diabetic patients with advanced kidney disease, yet still produced meaningful improvements across vascular and metabolic parameters, and inflammatory markers with a simple, inexpensive form of magnesium (magnesium oxide). (5)
Talari, Hamid Reza, et al. “Effects of Magnesium Supplementation on Carotid Intima–Media Thickness and Metabolic Profiles in Diabetic Haemodialysis Patients: A Randomised, Double-Blind, Placebo-Controlled Trial.” British Journal of Nutrition, vol. 121, no. 7, 2019, pp. 809–817.
Magnesium in our Calcium Score Protocol Prevents Atherosclerosis and Arrhythmia.
